Koninklijke Philips N.V. (PHG)
Pre-Market:
| Previous Close | 20.48 |
| Open | 20.64 |
| Bid | 20.81 x 1200 |
| Ask | 20.83 x 3000 |
| Day's Range | 20.48 - 20.75 |
| 52 Week Range | 11.75 - 23.30 |
| Volume | |
| Avg. Volume | 1,006,446 |
| Market Cap | 19.053B |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 12, 2022 |
| 1y Target Est | N/A |
- GlobeNewswire
Philips extends its mobile C-arm range with Zenition 30, alleviating staff shortages by empowering surgeons with greater personalization and control
Philips Zenition 30 in use Philips Zenition 30 product photo September 13, 2023 Offering surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition, Philips’ new Zenition 30 reduces dependency on technician support for a wide variety of minimally invasive procedures Advanced imaging algorithms contribute to outstanding image quality and dose efficiency Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology,
- GlobeNewswire
Philips reaches resolution of US economic loss litigation
September 7, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the company and certain of its US subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation (MDL) related to Philips Respironics’ voluntary recall of certain sleep and respiratory care devices. This settlement, which is expected to be submitted to the US District Court for the Western District of Pennsylvania
- GlobeNewswire
Philips successfully prices offering of Notes for EUR 500 million to be used for repayment of existing debt, resulting in a debt-neutral effect
August 30, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its issue of EUR 500 million fixed rate notes due 2031 (the “Notes”) under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect. The net proceeds of the offering will be used for repayment of EUR 500 million utilized and outstanding under the credit facility entered into in Q4 2022 and fo
